| Hillside Manor Healthcare And Rehab Center | |
| 1265 Mclaran Avenue, Saint Louis, Missouri 63147 | |
| (314) 388-4121 | |
| Name | Hillside Manor Healthcare And Rehab Center |
|---|---|
| Location | 1265 Mclaran Avenue, Saint Louis, Missouri |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 208 |
| Occupancy Rate | 57.26% |
| Medicare ID (CCN) | 265585 |
| Legal Business Name | Hillside Manor Healthcare & Rehab. Center |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1104590975 |
| Organization Name | HILLSIDE OPERATOR LLC |
| Address | 1265 Mclaran Ave, Saint Louis, MO 63147 |
| Phone Number | 314-388-4121 |
News Archive
Largest reported investigation to date shows no significant association between talcum powder and increased ovarian cancer risk.
The Society of Thoracic Surgeons has released a set of clinical practice guidelines to address major advances in the evaluation and management of patients with aortic valve disease.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
A new study finds breast cancer survivors in general have higher risk of new cancer diagnosis compared to healthy individuals.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
› Verified 8 days ago
| NPI Number | 1275507139 |
| Organization Name | HILLSIDE MANOR HEALTHCARE & REHAB. CENTER |
| Address | 1265 Mclaran Ave, Saint Louis, MO 63147 |
| Phone Number | 314-388-4121 |
News Archive
Largest reported investigation to date shows no significant association between talcum powder and increased ovarian cancer risk.
The Society of Thoracic Surgeons has released a set of clinical practice guidelines to address major advances in the evaluation and management of patients with aortic valve disease.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
A new study finds breast cancer survivors in general have higher risk of new cancer diagnosis compared to healthy individuals.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Largest reported investigation to date shows no significant association between talcum powder and increased ovarian cancer risk.
The Society of Thoracic Surgeons has released a set of clinical practice guidelines to address major advances in the evaluation and management of patients with aortic valve disease.
Apitope, the European drug discovery and development company focused on treating the underlying cause of autoimmune diseases, today announced completion of recruitment into its second Phase I clinical trial of ATX-MS-1467 in patients with multiple sclerosis (MS).
A new study finds breast cancer survivors in general have higher risk of new cancer diagnosis compared to healthy individuals.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $9750 |
| Number of Payment Denials | 1 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 11.23 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 11.93 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.41 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.23 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.89 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.99 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.01 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 30.22 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 68.63 | 83.88 |